These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3899840)

  • 1. Indomethacin and chloroquine fail to inhibit fluid loss in cholera.
    Rabbani GH; Butler T
    Gastroenterology; 1985 Nov; 89(5):1035-7. PubMed ID: 3899840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled trial.
    Rabbani GH; Butler T; Bardhan PK; Islam A
    Lancet; 1983 Dec 24-31; 2(8365-66):1439-42. PubMed ID: 6140541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae.
    Molla AM; Gyr K; Bardhan PK; Molla A
    Gastroenterology; 1984 Oct; 87(4):845-7. PubMed ID: 6147293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug targets for cholera therapy.
    Thiagarajah JR; Verkman AS
    Trends Pharmacol Sci; 2005 Apr; 26(4):172-5. PubMed ID: 15808339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins.
    Rabbani GH
    Dan Med Bull; 1996 Apr; 43(2):173-85. PubMed ID: 8741209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double blind trial of aspirin versus placebo in cholera and non-cholera diarrhoea.
    Islam A; Bardhan PK; Islam MR; Rahman M
    Trop Geogr Med; 1986 Sep; 38(3):221-5. PubMed ID: 3529538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously.
    Rabbani GH; Greenough WB; Holmgren J; Kirkwood B
    Br Med J (Clin Res Ed); 1982 May; 284(6326):1361-4. PubMed ID: 6803977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions.
    Hirschhorn N; Kinzie JL; Sachar DB; Northrup RS; Taylor JO; Ahmad SZ; Phillips RA
    N Engl J Med; 1968 Jul; 279(4):176-81. PubMed ID: 4968807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of clonidine hydrochloride as an antisecretory agent in cholera.
    Rabbani GH; Butler T; Patte D; Abud RL
    Gastroenterology; 1989 Aug; 97(2):321-5. PubMed ID: 2663610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for cholera antagonists.
    Nalin DR
    Lancet; 1977 Jan; 1(8001):46-7. PubMed ID: 63687
    [No Abstract]   [Full Text] [Related]  

  • 11. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation.
    Pongkorpsakol P; Satitsri S; Wongkrasant P; Chittavanich P; Kittayaruksakul S; Srimanote P; Chatsudthipong V; Muanprasat C
    Eur J Pharmacol; 2017 Mar; 798():94-104. PubMed ID: 28119077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of intraluminal toxin in cholera: trial of GM1 ganglioside charcoal.
    Stoll BJ; Holmgren J; Bardhan PK; Huq I; Greenough WB; Fredman P; Svennerholm L
    Lancet; 1980 Oct; 2(8200):888-91. PubMed ID: 6107548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults.
    Alam NH; Ashraf H; Sarker SA; Olesen M; Troup J; Salam MA; Gyr N; Meier R
    Digestion; 2008; 78(1):24-9. PubMed ID: 18769066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpromazine reduces fluid-loss in cholera.
    Rabbani GH; Greenough WB; Holmgren J; Lönnroth I
    Lancet; 1979 Feb; 1(8113):410-2. PubMed ID: 84263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases.
    Islam MR; Sack DA; Holmgren J; Bardhan PK; Rabbani GH
    Gastroenterology; 1982 Jun; 82(6):1335-40. PubMed ID: 7040157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen (Brufen) in cholera and other diarrhoeas.
    De S; Sircar BK; Sasmal D; De SP; Mondal A
    Indian J Med Res; 1974 May; 62(5):756-64. PubMed ID: 4611912
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised double blind trial of single dose doxycycline for treating cholera in adults.
    Alam AN; Alam NH; Ahmed T; Sack DA
    BMJ; 1990 Jun; 300(6740):1619-21. PubMed ID: 2196962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacolene in cholera: a double blind randomized controlled trial.
    Patra FC; Majumder RN; Eeckels R; Desjeux JF; Mahalanabis D
    Scand J Infect Dis; 1999; 31(2):151-4. PubMed ID: 10447324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.
    Gore SM; Fontaine O; Pierce NF
    BMJ; 1992 Feb; 304(6822):287-91. PubMed ID: 1531430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal fluid and electrolyte transport in human cholera.
    Banwell JG; Pierce NF; Mitra RC; Brigham KL; Caranasos GJ; Keimowitz RI; Fedson DS; Thomas J; Gorbach SL; Sack RB; Mondal A
    J Clin Invest; 1970 Jan; 49(1):183-95. PubMed ID: 5409804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.